Regulatory T Cells in γ Irradiation-Induced Immune Suppression

• Hugh I. McFarland ,

  * E-mail: hugh.mcfarland@fda.hhs.gov

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Montserrat Puig,

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Lucja T. Grajkowska,

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Kazuhide Tsuji,

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Jay P. Lee,

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Karen P. Mason,

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Daniela Verthelyi,

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Amy S. Rosenberg

  Affiliation Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯